Company / Depreciation & Amortization
Oric Pharmaceuticals, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.2M
FY2025
5-year range
$897.0K / $1.2M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#119 of 168
Health Care
What the data says
At $1M, Oric Pharmaceuticals, Inc.'s depreciation & amortization ranks #50 of 168 in the Health Care sector. Depreciation & Amortization has increased for 4 consecutive years, from $897,000 in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +4.7%.
Increased from $1M to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#50 of 168 in Health CareTop 29% of 168This company $1.2M Sector average $212.9M
▼
-99.4% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 5-year CAGR of +4.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 10.2% year-over-year.
- Ranks #119 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +10.2% |
| FY2024 | $1.1M | +7.3% |
| FY2023 | $1.0M | +6.8% |
| FY2022 | $966.0K | +7.7% |
| FY2021 | $897.0K | -7.5% |
| FY2020 | $970.0K | -5.6% |
| FY2019 | $1.0M | +13.8% |
| FY2018 | $903.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026